Methods of identifying pancreatic cancer cells

Details Methods of identifying pancreatic cancer cells Methods of identifying pancreatic cancer cells

2008-03-03

2010-10-19

Reddig, Peter J (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S007210, C435S007230

Reexamination Certificate

active

07816082

ABSTRACT:
Methods that identify cells as pancreatic cancer cells based on assessing the expression of combinations of target molecules expressed preferentially on pancreatic cancer cells are disclosed. Combinations were initially discovered by microarray analysis and selected based upon tumor specificity, relative lack of cross-reactivity with normal tissues, and applicability as targets of multispecific ligands. The claimed methods encompass measuring the expression of three or more specific target molecules in combination and correlating positive expression of the combination with an identification of the cell as a pancreatic cancer cell.

REFERENCES:
patent: 2003/0105000 (2003-06-01), Pero et al.
patent: 2004/0180002 (2004-09-01), Young et al.
Greenbaum et al. (Genome Biology, 2003, vol. 4, Issue 9, pp. 117.1-117.8).
Brennan et al. (J. Autoimmunity, 1989, 2 (suppl.): 177-186).
Zimmer (Cell Motility and the Cytoskeleton, 1991. 20:325-337).
Hell et al. (Laboratory Investigation, 1995, 73: 492-496).
Fu et al. (EMBO J., 1996, 15:43982-4401).
Vallejo et al. (Biochimie, 2000 82:1129-1133).
Rudikoff et al. (Proc. Natl. Acad. Sci., USA, 1982, 79: 1979-1983).
Coleman et al. (Research in Immunology, 1994; 145(1): 33-36).
Abaza et al. (Journal of Protein Chemistry, vol. 11, No. 5, 1992, pp. 433-444).
Burgess et al. (J of Cell Bio. 111:2129-2138, 1990).
Gura (Science, 1997, 278:1041-1042).
Kaiser (Science, 2006, 313: 1370).
Benedict et al. (J. Exp. Medicine, 2001, 193(1) 89-99).
Jiang et al. (J. Biol. Chem., 2003, 278(7) 4763-4769).
Matsushita et al. (FEBS Letters, 1999, vol. 443, pp. 348-352).
Singh et al. (Glycobiology, 2001, vol. 11, pp. 587-592).
Bowie et al. (Science, 1990, 257:1306-1310).
Lazar et al (Molecular and Cellular Biology, 1988, 8:1247-1252).
Jemal A et al, Cancer Statistics, CA Cancer J Clin 56 106-130 (Mar./Apr. 2006).
Hale G, Therapeutic antibodies—Delivering the promise?, Adv Drug Deliv Rev, 58 633-639 (May 2006).
Pegram MD et al, Targeted therapy: wave of the future. J Clin Oncol 23 1776-1781 (2005).
Reichert JM et al, Monoclonal antibody successes in the clinic. Nat Biotechnol 23 1073-1078 (2005).
Richter M and Zhang H, Receptor-targeted cancer therapy. DNA Cell Biol 24 271-282 (2005).
Sawyers C, Targeted cancer therapy, Nature, 432 294-297 (2004).
Vasir JK and V Labhasetwar, Targeted drug delivery in cancer therapy,Technol Cancer Res Treat, 4 363-374 (2005).
Moore MJ, Brief communication: a new combination in the treatment of advanced pancreatic cancer, Semin Oncol 32 5-6 (2005).
Handl HL et al, Hitting multiple targets with multimeric ligands, Expert Opin Ther Targets, 8 565-586 (2004).
Vagner J et al, Novel targeting strategy based on multimeric ligands for drug delivery and molecular imaging: homooligomers of alpha-MSH, Bioorg Med Chem Let 14 211-215 (2004).
Son CG et al, Database of mRNA gene expression profiles of multiple human organs, Genome Res 15 443-450 (2005).
Shyamsundar R et al, A DNA microarray survey of gene expression in normal human tissues, Genome Biol 6 R22.1-R22.7 (2005).
Nocito A et al, Tissue microarrays (TMAs) for high-throughput molecular pathology research, Int J Cancer, 94 1-5 (2001).
Torhorst J et al, Tissue microarrays for rapid linking of molecular changes to clinical endpoints, Am J Pathol 159 2249-2256 (2001).
Kononen J et al, Tissue microarrays for high throughput molecular profiling of tumor specimens, Nat Med 4 844-847 (1998).
Haubner R et al, Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD, PLoS Med, 2, 0244-0252 (2005).
Beer AJ et al, PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression, J Nucl Med 47, 763-769 (May 2006).
Goldenberg DM and Sharkey RM. Novel radiolabeled antibody conjugates, Oncogene 26 3734-3744 (May 2007).
Jhanwar YS and Divgi C, Current status of therapy of solid tumors, J Nucl Med 46 141S-150S (2005).
Boturyn et al, Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis, J Am Chem Soc, 126 5730-5739 (2004).
Laugel B et al, Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibition, J Biol Chem 280 1882-1892 (2005).
Garanger E et al, Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands, Org Biomol Chem, 4 1958-1965 (Apr. 2006).
Mammen M et al, Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors, Angewandte Chemie 37 2754-2796 (1998).
Boyd RS et al, Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B, Leukemia 17 1605-1612 (2003).
Zhao Y et al, Proteomic analysis of integral plasma membrane proteins. Anal Chem, 76 1817-1823 (2004).
Loyet KM et al, Proteomic profiling of surface proteins on Th1 and Th2 cells. J Proteome Res, 4 400-409 (2005).
Dougherty ER et al, Inference from clustering with application to gene-expression microarrays, J Comput Biol, 9 105-126 (2002).
Andersen Cl et al, Improved procedure for fluorescence in situ hybridization on tissue microarrays, Cytometry 45 83-86 (2001).
Mousses S et al. Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays, Cancer Res 62 1256-1260 (2002).
Morse DL et al, Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction, Anal Biochem 342 69-77 (2005).
Lynch RM et al, Modulation of hexokinase association with mitochondria analyzed with quantitative three-dimensional confocal microscopy, J Cell Biol 112 385-395 (1991).
Rose A, The sensitivity performance of the human eye on an absolute scale, J Opt Soc Am 38 196-208 (1948).

Affiliated with

Also associated with

Rating

Methods of identifying pancreatic cancer cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of identifying pancreatic cancer cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of identifying pancreatic cancer cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4223680